Literature DB >> 24847117

Nongenomic thyroid hormone signaling occurs through a plasma membrane-localized receptor.

Hema Kalyanaraman1, Raphaela Schwappacher1, Jisha Joshua1, Shunhui Zhuang1, Brian T Scott1, Matthew Klos2, Darren E Casteel1, John A Frangos3, Wolfgang Dillmann1, Gerry R Boss1, Renate B Pilz4.   

Abstract

Thyroid hormone (TH) is essential for vertebrate development and the homeostasis of most adult tissues, including bone. TH stimulates target gene expression through the nuclear thyroid receptors TRα and TRβ; however, TH also has rapid, transcription-independent (nongenomic) effects. We found a previously uncharacterized plasma membrane-bound receptor that was necessary and sufficient for nongenomic TH signaling in several cell types. We determined that this receptor is generated by translation initiation from an internal methionine of TRα, which produces a transcriptionally incompetent protein that is palmitoylated and associates with caveolin-containing plasma membrane domains. TH signaling through this receptor stimulated a pro-proliferative and pro-survival program by increasing the intracellular concentrations of calcium, nitric oxide (NO), and cyclic guanosine monophosphate (cGMP), which led to the sequential activation of protein kinase G II (PKGII), the tyrosine kinase Src, and extracellular signal-regulated kinase (ERK) and Akt signaling. Hypothyroid mice exhibited a cGMP-deficient state with impaired bone formation and increased apoptosis of osteocytes, which was rescued by a direct stimulator of guanylate cyclase. Our results link nongenomic TH signaling to a previously uncharacterized membrane-bound receptor, and identify NO synthase, guanylate cyclase, and PKGII as TH effectors that activate kinase cascades to regulate cell survival and proliferation.
Copyright © 2014, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24847117      PMCID: PMC6504257          DOI: 10.1126/scisignal.2004911

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  40 in total

Review 1.  Nongenomic actions of thyroid hormone.

Authors:  Paul J Davis; Fernando Goglia; Jack L Leonard
Journal:  Nat Rev Endocrinol       Date:  2015-12-15       Impact factor: 43.330

2.  Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition.

Authors:  Brijesh K Singh; Rohit A Sinha; Jin Zhou; Madhulika Tripathi; Kenji Ohba; Mu-En Wang; Inna Astapova; Sujoy Ghosh; Anthony N Hollenberg; Karine Gauthier; Paul M Yen
Journal:  J Biol Chem       Date:  2015-10-09       Impact factor: 5.157

3.  A Novel, Direct NO Donor Regulates Osteoblast and Osteoclast Functions and Increases Bone Mass in Ovariectomized Mice.

Authors:  Hema Kalyanaraman; Ghania Ramdani; Jisha Joshua; Nadine Schall; Gerry R Boss; Esther Cory; Robert L Sah; Darren E Casteel; Renate B Pilz
Journal:  J Bone Miner Res       Date:  2016-09-07       Impact factor: 6.741

Review 4.  Thyroid hormone and anti-apoptosis in tumor cells.

Authors:  Hung-Yun Lin; Gennadi V Glinsky; Shaker A Mousa; Paul J Davis
Journal:  Oncotarget       Date:  2015-06-20

Review 5.  Minireview: nuclear receptor regulation of osteoclast and bone remodeling.

Authors:  Zixue Jin; Xiaoxiao Li; Yihong Wan
Journal:  Mol Endocrinol       Date:  2014-12-30

6.  Thyroid Hormone Signaling Pathways: Time for a More Precise Nomenclature.

Authors:  Frédéric Flamant; Sheue-Yann Cheng; Anthony N Hollenberg; Lars C Moeller; Jacques Samarut; Fredric E Wondisford; Paul M Yen; Samuel Refetoff
Journal:  Endocrinology       Date:  2017-07-01       Impact factor: 4.736

7.  Inhibition of thyroid hormone receptor locally in the retina is a therapeutic strategy for retinal degeneration.

Authors:  Hongwei Ma; Fan Yang; Michael R Butler; Joshua Belcher; T Michael Redmond; Andrew T Placzek; Thomas S Scanlan; Xi-Qin Ding
Journal:  FASEB J       Date:  2017-04-20       Impact factor: 5.191

Review 8.  A review of the peripheral levels of regulation by thyroid hormone.

Authors:  Alexander G Little
Journal:  J Comp Physiol B       Date:  2016-04-09       Impact factor: 2.200

9.  Noncanonical thyroid hormone signaling mediates cardiometabolic effects in vivo.

Authors:  G Sebastian Hönes; Helena Rakov; John Logan; Xiao-Hui Liao; Eugenie Werbenko; Andrea S Pollard; Stine M Præstholm; Majken S Siersbæk; Eddy Rijntjes; Janina Gassen; Sören Latteyer; Kathrin Engels; Karl-Heinz Strucksberg; Petra Kleinbongard; Denise Zwanziger; Jan Rozman; Valerie Gailus-Durner; Helmut Fuchs; Martin Hrabe de Angelis; Ludger Klein-Hitpass; Josef Köhrle; David L Armstrong; Lars Grøntved; J H Duncan Bassett; Graham R Williams; Samuel Refetoff; Dagmar Führer; Lars C Moeller
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-11       Impact factor: 11.205

10.  Type 2 Iodothyronine Deiodinase Activity Is Required for Rapid Stimulation of PI3K by Thyroxine in Human Umbilical Vein Endothelial Cells.

Authors:  Tomoyuki Aoki; Katsuhiko Tsunekawa; Osamu Araki; Takayuki Ogiwara; Makoto Nara; Hiroyuki Sumino; Takao Kimura; Masami Murakami
Journal:  Endocrinology       Date:  2015-08-18       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.